EP Patent

EP2305683B1 — Pharmaceutical dosage form comprising oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone

Assigned to Euro Celtique SA · Expires 2015-01-28 · 11y expired

What this patent protects

Patent listed against oxymorphone-hydrochloride.

Drugs covered by this patent

oxymorphone-hydrochloride (OXYMORPHONE HYDROCHLORIDE)

Patent Metadata

Patent number: EP2305683B1
Jurisdiction: EP
Classification: —
Expires: 2015-01-28
Drug substance claim: No
Drug product claim: No
Assignee: Euro Celtique SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.